Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Buck

Showing results (321-330 of 337) with videos related to

Pageof 34
Sort By:
Stroke|July 18, 2025
Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT TrialSajeevan Sujanthan, Gayathiri Rajkumar, Katie N Dainty, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 8, 2025
The Acute Stroke System of Treatment Across Canada: Findings from a National Stroke Centre SurveyBetty Adewusi, Andrew M Demchuk, Grant Stotts, et al.
Stroke|March 24, 2025
Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT TrialNishita Singh, Fouzi Bala, Ayoola Ademola, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 21, 2023
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trialFouzi Bala, Mohammed Almekhlafi, Nishita Singh, et al.
Stroke|June 23, 2025
COSMOS: Interrater and Intrarater Reliability Study of a Novel Outcome MeasureMayank Goyal, Aravind Ganesh, Salome L Bosshart, et al.
Stroke|September 7, 2023
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S Field, Vanessa Dizonno, Mohammed A Almekhlafi, et al.
Journal of Extracellular Vesicles|January 5, 2023
Special considerations for studies of extracellular vesicles from parasitic helminths: A community-led roadmap to increase rigour and reproducibilityRuby White, Javier Sotillo, María Eugenia Ancarola, et al.
Journal of Extracellular Vesicles|March 23, 2017
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paperBogdan Mateescu, Emma J K Kowal, Bas W M van Balkom, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
Pageof 34

Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
Stroke|July 18, 2025
Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT TrialSajeevan Sujanthan, Gayathiri Rajkumar, Katie N Dainty, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 8, 2025
The Acute Stroke System of Treatment Across Canada: Findings from a National Stroke Centre SurveyBetty Adewusi, Andrew M Demchuk, Grant Stotts, et al.
Stroke|March 24, 2025
Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT TrialNishita Singh, Fouzi Bala, Ayoola Ademola, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 21, 2023
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trialFouzi Bala, Mohammed Almekhlafi, Nishita Singh, et al.
Stroke|June 23, 2025
COSMOS: Interrater and Intrarater Reliability Study of a Novel Outcome MeasureMayank Goyal, Aravind Ganesh, Salome L Bosshart, et al.
Stroke|September 7, 2023
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S Field, Vanessa Dizonno, Mohammed A Almekhlafi, et al.
Journal of Extracellular Vesicles|January 5, 2023
Special considerations for studies of extracellular vesicles from parasitic helminths: A community-led roadmap to increase rigour and reproducibilityRuby White, Javier Sotillo, María Eugenia Ancarola, et al.
Journal of Extracellular Vesicles|March 23, 2017
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paperBogdan Mateescu, Emma J K Kowal, Bas W M van Balkom, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
Pageof 34